• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE-TEX VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE-TEX VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Obstruction/Occlusion (2422)
Event Date 01/04/2011
Event Type  Death  
Manufacturer Narrative
(b)(4).
 
Event Description
The following information was received through literature surgical management of pulmonary atresia with ventricular septal defect: early total correction versus shunt published by the society of thoracic surgeons, ann thorac surg 2011;91:1928 35.The study was to compare the surgical outcomes of shunt and early total correction.From 1997 to 2008, 47 patients with pulmonary atresia with ventricular septal defect and no major aortopulmonary collateral arteries who underwent surgical correction were enrolled in this retrospective study.Twenty-nine patients underwent palliative shunt operation (group s).The most commonly used shunt size was 3.5 mm in diameter (n=17) and this was followed by a 4-mm size shunt (n=8) with a gore-tex vascular graft (w.L.Gore assoc.Inc, (b)(4)).The results state that in terms of complications, in the shunt group, these interstage mortalities had the possibility of being associated with critical stenosis or occlusion of the shunt (4 patients).
 
Manufacturer Narrative
Literature citation: the literature name: ¿surgical management of pulmonary atresia with ventricular septal defect: early total correction versus shunt¿ published by the society of thoracic surgeons, ann thorac surg 2011;91:1928 ¿35.Accepted for publication jan 4, 2011.The authors: jae gun kwak, md, chang-ha lee, md, cheul lee, md, and chun soo park.Department of thoracic and cardiovascular surgery, sejong general hospital, bucheon, republic of korea doi:10.1016/j.Athoracsur.2011.01.014.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11918618
MDR Text Key253675637
Report Number2017233-2021-02047
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
PMA/PMN Number
K802095
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 07/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/19/2021
Initial Date FDA Received06/02/2021
Supplement Dates Manufacturer Received05/19/2021
Supplement Dates FDA Received07/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age40 DA
-
-